News from

News Archive

Every story published by Penn Today—all in one place.
Reset All Filters
7424 Results
Penn’s urban forest in fall
autumn leaves at the quad

nocred

Penn’s urban forest in fall

Penn’s West Philadelphia campus is home to 240 different tree species, which put on a show during the fall season.

Kristina García

Who, What, Why: John Donges
John Donges sitting on a bench in an outside courtyard

John Donges, Penn Vet associate director of marketing, has just completed the 100th issue of the School's Bellwether magazine as guest editor. 

nocred

  • Who, What, Why

    • Who, What, Why: John Donges

    At Penn Vet for more than two decades, John Donges has worked on nearly half the issues of Bellwether, the School’s alumni and donor magazine. So, it made sense that he was the editor of a special 100th issue, publishing this month.
    How the modern story of postwar anti-racism ignored the Global South
    Left: Book cover for “The Remnants or Race Science,”; right, Sebastián Gil-Riaño.

    Sebastián Gil-Riaño, an assistant professor in the Department of History and Sociology of Science, is the author of “The Remnants of Race Science: UNESCO and Economic Development in the Global South.”

    (Images: Courtesy of OMNIA; portrait by Adriann Moss)

    How the modern story of postwar anti-racism ignored the Global South

    In his new book, science historian Sebastián Gil-Riaño explores the lives of scientists who shaped one of the first international efforts to combat racism—and then got left out of the story.

    From Omnia

    Lipid nanoparticles that deliver mRNA to T cells hold promise for autoimmune diseases
    From left to right: Ajay Thatte, Benjamin Nachod, Rohan Palanki, Kelsey Swingle, Alex Hamilton, and Michael Mitchell in the Mitchell lab.

    From left to right: Ajay Thatte, Benjamin Nachod, Rohan Palanki, Kelsey Swingle, Alex Hamilton, and Michael Mitchell.

    (Image: Courtesy of the Mitchell Lab)

    Lipid nanoparticles that deliver mRNA to T cells hold promise for autoimmune diseases

    A new platform to engineer adoptive cell therapies for specific autoimmune diseases has the potential to create therapies for allergies, organ transplants, and more.

    From Penn Engineering Today